BioRem Inc. (CVE:BRM – Get Free Report) Director Derek Webb sold 120,000 shares of the company’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of C$2.93, for a total transaction of C$351,600.00.
BioRem Stock Performance
Shares of BioRem stock opened at C$2.97 on Wednesday. The company has a debt-to-equity ratio of 48.97, a current ratio of 1.57 and a quick ratio of 1.08. The firm has a market cap of C$46.63 million, a price-to-earnings ratio of 14.14 and a beta of 0.85. BioRem Inc. has a one year low of C$0.88 and a one year high of C$3.39. The stock’s 50-day moving average is C$2.68 and its 200-day moving average is C$2.32.
BioRem Company Profile
Recommended Stories
- Five stocks we like better than BioRem
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- Stock Analyst Ratings and Canadian Analyst Ratings
- Netflix Is On Track To Hit $1,000 By Christmas
- How to Use the MarketBeat Dividend Calculator
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for BioRem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRem and related companies with MarketBeat.com's FREE daily email newsletter.